Names in the News.
*Darrell Campbell, Jr., MD, a transplant surgeon at the University of Michigan, has been named the recipient of the John M. Eisenberg Award for Individual Achievement, a joint award from the National Quality Forum and the Joint Commission. He led the expansion of the National Surgical Quality Improvement Program (NSQIP) from the Veterans Administration to the private sector, and then used that experience to design and develop the Michigan Surgical Quality Collaborative (MSQC), a quality collaborative based on NSQIP.
*Bruce Robinson, MD, MS, has been named Vice President of Research at the Arbor Research Collaborative for Health in Ann Arbor, MI. Robinson had been an associate director at Merck, Inc. from 2005 to 2007.
*Robert Lanza, PhD, has been promoted to the position of Chief Scientific Officer at Advanced Cell Technology (ACT), Worcester, MA. Lanza, who joined ACT in 1999, developed and managed several of the company's human embryonic stem cell research programs including the Retinal Pigment Epithelial Cell Program, the Hemagioblast Cell Program and the Somatic Cell Nuclear Transfer research. Simultaneous to Lanza's promotion, Michael West voluntarily stepped down as ACT's president and chief scientific officer to pursue new opportunities in cell research and technology. He will remain as a director of the company and serve as a consultant with ACT until the end of the year.
*The United Network for Organ Sharing (UNOS)/Organ Procurement and Transplantation Network (OPTN) Nominating Committee has announced its slate of nominees for the 2008-2009 Board of Directors (check). They include: President - Robert S.D. Higgins, MD, MSHA, Rush University Medical Center, Chicago, IL; Vice President (vote for one) - Jean Emond, MD, New York Presbyterian/Columbia University Medical Center, New York, NY, and James Wynn, MD, Medical College of Georgia, Augusta; Vice President for Patient and Donor Affairs (vote for one) - M. Jill McMaster, MA, CAPT USNR (Ret), Kingston, NY, and Flora Solarz, MPS, ATR, New York, NY; Immediate Past President - Timothy Pruett, MD, University of Virginia Health Sciences Center, Charlottesville; Secretary (vote for one) - Mitchell Henry, MD, Ohio State University Hospitals, Columbus, OH, and Ruth McDonald, MD, Children's Hospital, Seattle, WA; Regional Councillors: Region 4 - John Goss, MD, Methodist Hospital, Houston, TX; Region 5 - Chris Friese, MD, University of California, San Francisco Medical Center, CA; Region 6 - Jorge Reyes, MD, University of Washington Medical Center, Seattle; Region 7 - John Lake, MD, University of Minnesota Medical Center, Minneapolis; Region 9 - Patricia Sheiner, MD, Westchester Medical Center, Hawthorne, NY; Heart Transplant Representative (vote for one)- Jon Kobashigawa, MD, UCLA Medical Center, Los Angeles, CA, and J. David Vega, MD, Emory Clinic, Atlanta, CA; At Large Representatives (vote for three) - Kristene Gugliuzza, MD, University of Texas Medical Branch, Galveston; Jimmy Light, MD, Washington Hospital Center, Washington, DC; David Mulligan, MD, Mayo Clinic, Rochester, MN; Mark Stegall, MD, Mayo Clinic, Rochester, MN; and Stuart Sweet, MD, PhD, St. Louis Children's Hospital, St. Louis, MO; At Large Organ Procurement Organization Representative (vote for one) - Elaine Berg, MPA, FACHE, New York Organ Donor Network, New York, NY, and Michael Seely, MS, CPTC, Pacific Northwest Transplant Bank, Portland, OR; Medical/Scientific Representatives (vote for two) - Jeffery Crippin, MD, Barnes-Jewish Hospital, St. Louis, MO, and Arthur Matas, MD, University of Minnesota/Fairview University Medical Center, Minneapolis, MN; General Public Representatives (number of members to be decided) - Donna Banks, Pleasantville, NY; Davaid Burgio, MPA. LFACHE, Lexington, KY; Michelle Desler, MS (need to ask); Leslie High, CFRE, Kansas City, MO; John C.F. Hodges, MA, Cambridge, MA; Bobby Howard, Norcross, GA; B. Lynn Martin, MPH, Tulsa, OK; Barbara Musto, Glen Cove, NY; Mark Norquist (don't know); Duborah Surlas, RN, AEE, Naples, FL, and Dolph Chianchiano, JD, MPA, National Kidney Foundation, New York, NY; Histocompatibility Representative - Deborah Crowe, PhD, D(ABHI), DCI Laboratory, Nashville, TN; Organ Procurement Organization Representative - Sue Dunn, MBA, RN, BSN, Donor Alliance, Denver, CO, and Transplant Coordinator Representative - Jan Finn, RN, MSN, CPTC, Midwest Transplant Network, Westwood, KS.
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 1, 2007|
|Previous Article:||2007 Nobel Prize for medicine shared by three scientists who discovered "gene targeting".|
|Next Article:||Osiris receives FDA ok to initiate Phase III pivotal trial for Prochymal as first line treatment for acute GVHD.|